共 50 条
- [2] Dupilumab (Dupixent) for Asthma MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1563): : 6 - 8
- [3] Risk of conjunctivitis associated with dupilumab (Dupixent®) ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2018, 145 (8-9): : 556 - 558
- [4] Dupilumab (Dupixent) for Moderate to Severe Atopic Dermatitis MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1519): : 64 - 66
- [5] Dupilumab (Dupixent) for Eosinophilic Esophagitis and Prurigo Nodularis MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1669): : 18 - 21
- [10] A response to therapy for COPD with dupilumab LANCET RESPIRATORY MEDICINE, 2025, 13 (01): : e3 - e3